Results 301 to 310 of about 337,810 (339)

Antiplatelet Treatment Strategy in MINOCA Patients: Predictors of Decision Making in Clinical Practice and Prognostic Implications. [PDF]

J Clin Med
Mantzouranis E, Leontsinis I, Vlachakis PK, Mihas C, Iliakis P, Dri E, Sakalidis A, Soulaidopoulos S, Fragoulis C, Milkas A, Tsiamis E, Tsiachris D, Dimitriadis K, Tsioufis K.   +13 more
europepmc   +1 more source

A Call to Action for Anticoagulation Stewardship to Address Suboptimal Thromboprophylaxis Practices for at-Risk Non-Orthopedic Surgical Patients in Vietnam: An Explanatory Sequential Mixed-Methods Study. [PDF]

Vasc Health Risk Manag
Nguyen TTT, Tong HT, Nguyen HTL, Nguyen TD.   +3 more
europepmc   +1 more source

Immediate deep vein thrombosis after trauma: Case report. [PDF]

Trauma Case Rep
Zamani M, Heidari F, Nasri Nasrabadi E.
europepmc   +1 more source

Evaluating the Effect of Concomitant Azoles on Anticoagulant Prescribing Practices in Transplant Patients: A National Survey of Clinicians. [PDF]

J Pharm Technol
Burroughs KM, Lichvar AB, Groetzinger LM, Horn E, Iasella CJ, Moore CA, Pierce DR, Sacha LM, Rivosecchi RM.   +8 more
europepmc   +1 more source

Newly identified cerebral microbleeds in patients on anticoagulation for secondary stroke prevention. [PDF]

Medicine (Baltimore)
Šrámková T, Vaňásek T, Šrámek M, Janský P, Benešová K, Olšerová A, Kmetonyová S, Paulasová-Schwabová J, Klíma M, Michal L, Kala D, Otáhal J, Mikšík L, Tomek A.   +13 more
europepmc   +1 more source

Perioperative Hemostasis Management During Open Mitral Valve Replacement in a Patient With Hypoprothrombinemia Secondary to Lupus Anticoagulant. [PDF]

Cureus
Nwanna-Nzewunwa O, Malik TM, Bellomy M, Shen YM, Saatee S, Heid C.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

New anticoagulants

Current Opinion in Hematology, 2006
Abstract Traditional anticoagulant drugs, including unfractionated heparin and warfarin, have several limitations. New anticoagulants have been developed that target a single coagulation factor and have predictable dose-response relationships. These include direct thrombin inhibitors and factor Xa inhibitors.
AGNELLI, Giancarlo, BECATTINI, Cecilia
openaire   +6 more sources

Anticoagulation

Clinical Obstetrics and Gynecology, 1998
Outpatient management of women requiring treatment and prophylaxis against thromboembolic conditions during pregnancy and the postpartum period requires a coordinated effort between the patient, her obstetrician and, in certain cases, a hematologic consultant.
H L, Brown, R A, Bobrowski
openaire   +2 more sources

Pharmacology of Anticoagulants

Disease-a-Month, 2012
Antithrombotic drugs are used for the prevention and treatment of thrombosis. Targeting the various components of thrombosis, these agents include (1) antiplatelet agents; (2) anticoagulants; and (3) fibrinolytic agents. This review focuses on anticoagulants.
Loke, Chandravathi, MD, Ali, Syed, MD, Johari, Vandita, MD   +2 more
openaire   +3 more sources